Neurology

medtech-news-for-fujirebio-stryker-abbott

Notizia - Recent Pharma, Healthcare and Biotech Happenings

FDA Clears Fujirebio’s Lumipulse® G Plasma Test for Detecting Alzheimer’s-Linked Amyloid Pathology; Stryker Gains FDA Clearance for OptaBlate® BVN System to Treat Chronic Low Back Pain; Abbott Unveils Clinical Evidence Linking Libre® CGM to Reduced Cardiovascular Events in Diabetes; GE HealthCare Launches AI-Based CleaRecon DL for Enhanced 3D Reconstruction in Interventional Suites; Philips Advances Cardiac Care with Launch of RADIQAL Clinical Study and Real-Time 3D Intracardiac Imaging Catheter in Europe

Explore More...
pharma-news-for-amgen-novartis-biogen

Amgen’s UPLIZNA Wins First FDA Nod for IgG4-Related Disease; Aldeyra Gets FDA CRL for Reproxalap in Dry Eye; Novartis’ Vanrafia Snags Accelerated FDA OK for IgAN Proteinuria; Biogen’s BIIB080 Earns Fast Track for Alzheimer’s; Epicrispr’s EPI-321 Cleared by FDA for FSHD

The Obesity Pandemic What can we do about it

The Obesity Pandemic: What Can we do About it?

medtech-news-for-caristo-lindus-health-gt-metabolic

Caristo Wins FDA Clearance for AI Solution to Prevent Heart Attacks; Lindus Health and Sooma Medical Announce Key Clinical Trial for MDD Device; GT Metabolic Secures FDA Clearance for Expanded 50mm MagDI System; Beckman Coulter’s DxC 500i Integrated Analyzer Earns FDA Clearance for Enhanced Diagnostics

Major Depressive Disorder Unveiling Market Moves and Commercial Breakthroughs

Major Depressive Disorder: Unveiling Market Moves and Commercial Breakthroughs

Major Depressive Disorder Treatment

Long-Awaited Victory: Fabre-Kramer’s Major Depressive Disorder Treatment Drug Gains FDA Approval

major-depressive-disorder-treatment-outlook

Will a Robust Pipeline Address the Major Depressive Disorder Treatment Conundrum?

7 Game-Changing Major Depressive Disorder Drugs in Development

7 Game-Changing Major Depressive Disorder Drugs in Development

medtech-news-for-medtronic-biomerica-alcon

Medtronic Secures FDA Approval for First-Ever Adaptive Deep Brain Stimulation System for Parkinson’s; FDA Grants Breakthrough Device Designation to Averto Medical’s ColoSeal™ System; Biomerica’s inFoods® IBS clinical trial findings were published in Gastroenterology; Lungpacer Medical’s STIMULUS Trial Highlights Improved Hemodynamics With Diaphragm Neurostimulation; Alcon Introduces Voyager DSLT; Stryker Finalizes Acquisition of Inari Medical

Alzheimer’s Treatment Latest Breakthroughs and Advancements in Therapeutic Development

Alzheimer’s Treatment: Latest Breakthroughs and Advancements in Therapeutic Development

Alzheimer's Disease: Navigating the Rising Incidence, Evolving Treatments, and Market Dynamics

Alzheimer’s Disease: Navigating the Rising Incidence, Evolving Treatments, and Market Dynamics

parkinsons-treatment

The Parkinson’s Treatment Landscape: Progressing Too Slowly for an Expanding Patient Base

spravato-for-treatment-resistant-depression

J&J’s SPRAVATO Achieves Milestone with Monotherapy Approval in Depression Treatment

medtech-news-for-agiliti-kubtc-neuvotion

Agiliti Launches Essentia; KUBTEC Introduces PICASSO Plus; FDA Clears Neuvotion’s NeuStim™ for Non-Invasive Hand Stimulation in Stroke & SCI Patients; Ibex Medical Analytics Achieves Milestone with FDA 510(k) Clearance; BlueWind Medical Reports Strong Two-Year Outcomes for Revi® System in Peer-Reviewed Study; Reprieve Cardiovascular’s FASTR Pilot Trial Shows Positive Outcomes, FDA Approves IDE for Next Phase

Semaglutide A Potential Game-Changer in Reducing Alzheimer's Disease Risk

Semaglutide: A Potential Game-Changer in Reducing Alzheimer’s Disease Risk

Challenges in the Pursuit of Alzheimer’s Disease Treatment Breakthroughs

Challenges in the Pursuit of Alzheimer’s Disease Treatment Breakthroughs: Drug Clinical Trial Failures

Can Remternetug Solve the Puzzle of Alzheimer’s

Can Remternetug Solve the Puzzle of Alzheimer’s?

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Days
loader